Huntington Bancshares Incorporated (HBAN) Stock Price & Analysis
Huntington Bancshares Incorporated (HBAN) closed at USD 15.66 on Thursday, October 22, 2026, down 0.38% on the day. The US market is currently closed (pre-market); this is not a live price.
The prior close was USD 15.72; the Oct 22, 2026 session ranged USD 15.47–15.89 on volume of 33,632,816 shares. Market capitalization is $31.64B, with a 52-week range of USD 14.82–19.46 (NMS). Source: Nexqual, retrieved October 23, 2026 at 08:35 UTC.
Also available as compact Markdown for AI agents: nexqual.com/HBAN.md
Latest Earnings Results (HBAN)
Huntington Bancshares Incorporated (HBAN) reported Q3 2026 results on Oct 22, 2026, 6:15:00 AM ET: GAAP EPS $0.33, revenue $2.79B vs. estimate $2.83B (miss). Guidance: Management expressed confidence that they are on track to meet financial targets. Source: company press release. Nexqual published it 3 min 28 s after release. Read the press release.
| Fiscal period | EPS (reported) | Revenue | Released | Source |
|---|---|---|---|---|
| Q3 2026 | $0.33 (GAAP diluted) | $2.79B | Oct 22, 2026, 6:15:00 AM ET · on Nexqual +3 min 28 s | PR Newswire |
Reported actuals captured by Nexqual from SEC 8-K filings and company press releases; each figure confirmed by two independent extraction methods.
Key facts (HBAN)
- Last four reported quarters (through Jun 30, 2026): revenue $9.72B, net income $2.40B (24.7% margin) (SEC filings).
- Valuation: P/E 13.2x (avg 11.3x at the last 3 fiscal year-ends).
- 1 of 80 tracked superinvestors hold HBAN (13F, Q2 2026): 0 new, 0 added, 1 reduced, 0 unchanged.
- Analysts: Buy (mean 2.14 on a 1–5 scale) (21 analysts), mean target USD 19.07 (range 17–22.5).
- Total return with dividends: 1Y +2.5% vs S&P 500 +14.9%; 5Y +17.1% vs S&P 500 +80.3%.
- Next earnings: 2026-10-22, EPS estimate USD 0.4, revenue estimate $2.86B.
Financials (SEC 10-K; TTM = last four 10-Q/10-K quarters) (HBAN)
| USD | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM |
|---|---|---|---|---|---|---|
| Revenue | $5.99B | $7.25B | $7.36B | $7.38B | $8.17B | $9.72B |
| Net income | $1.29B | $2.24B | $1.95B | $1.94B | $2.21B | $2.40B |
| EPS (diluted) | $0.90 | $1.45 | $1.24 | $1.22 | $1.39 | — |
| Free cash flow | $1.81B | $3.81B | $2.52B | $1.69B | $2.21B | $2.68B |
| Net margin | 21.6% | 30.9% | 26.5% | 26.3% | 27.1% | 24.7% |
| Revenue growth | +24.4% | +21.1% | +1.5% | +0.3% | +10.6% | — |
| Cash + short-term investments | $5.52B | $6.70B | $10.1B | $12.8B | $13.5B | — |
| Total debt | $7.44B | $11.7B | $13.0B | $16.6B | $18.5B | — |
Fiscal years end Dec. EPS is split-adjusted.
Valuation (price ÷ last four quarters, through Jun 30, 2026) (HBAN)
P/E 13.2x · P/S 3.3x · P/FCF 11.8x · P/B 1.0x · FCF yield 8.48% · Earnings yield 7.58% · Dividend yield (paid, TTM) 3.22%
P/E at fiscal year-ends: Dec 2025 11.8x, Dec 2024 12.4x, Dec 2023 9.6x.
Superinvestors (SEC 13F-HR, Q2 2026) (HBAN)
1 of 80 tracked investors hold HBAN. Each row is the investor's latest 13F; change is vs their prior-quarter share count.
| Investor | Firm | % of portfolio | Value | Change |
|---|---|---|---|---|
| Mairs & Power | Mairs & Power Funds | <0.01% | $464K | Reduced -3.9% |
Analysts (HBAN)
Consensus Buy (mean 2.14 on a 1–5 scale), 21 analysts; mean target USD 19.07 (low 17, high 22.5).
Rating changes, last 120 days:
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-06 | Keefe, Bruyette & Woods | Target lowered | Market Perform | $19.5 → $18 |
| 2026-10-05 | UBS | Target lowered | Buy | $22 → $19 |
| 2026-10-02 | JP Morgan | Target lowered | Overweight | $19.5 → $17.5 |
| 2026-09-23 | Truist Securities | Target lowered | Buy | $20 → $19 |
| 2026-09-21 | DA Davidson | Target lowered | Buy | $22 → $20 |
| 2026-09-18 | Evercore ISI Group | Target lowered | Outperform | $20 → $18 |
| 2026-09-16 | Wells Fargo | Target lowered | Overweight | $23 → $21 |
| 2026-08-18 | RBC Capital | Reiterated | Outperform | $21 |
| 2026-08-17 | Wells Fargo | Initiated | Overweight | $23 |
| 2026-07-28 | Evercore ISI Group | Target lowered | Outperform | $21 → $20 |
| 2026-07-28 | Truist Securities | Target raised | Buy | $19 → $20 |
| 2026-07-27 | B of A Securities | Downgrade | Buy → Neutral | $20 → $18.5 |
Total return (dividends reinvested) (HBAN)
| 1Y (from 2025-10-23) | 5Y (from 2021-10-18) | |
|---|---|---|
| Total return | +2.5% | +17.1% |
| S&P 500 (SPY) | +14.9% | +80.3% |
| Per year | +2.5% | +3.2% |
| Volatility (annualized) | 26.0% | 32.0% |
| Max drawdown | -21.3% (Feb 2026→Mar 2026) | -44.2% (Jan 2022→May 2023) |
HBAN revenue by business segment (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Consumer & Regional Banking | $362.0M | 72.1% | +22.7% |
| Commercial Banking | $136.0M | 27.1% | +61.9% |
| Total revenue | $502.0M | 100% | — |
HBAN revenue by product line (quarter ended Jun 30, 2026)
| Line | Revenue | Share of total | YoY |
|---|---|---|---|
| Payments and cash management revenue | $134.0M | 26.7% | +14.5% |
| Wealth and asset management revenue | $128.0M | 25.5% | +30.6% |
| Customer deposit and loan fees | $72.0M | 14.3% | +24.1% |
| Insurance income | $17.0M | 3.4% | -10.5% |
| Capital markets and advisory fees | $7.0M | 1.4% | +250.0% |
| Leasing revenue | $2.0M | 0.4% | — |
| Other noninterest income | $2.0M | 0.4% | +100.0% |
| Total revenue | $502.0M | 100% | — |
As tagged by the company in its SEC 10-Q / 10-K filings (XBRL).
HBAN suppliers, customers and competitors (named in its 10-K)
| Relationship | Company | Sentence in the filing |
|---|---|---|
| Customer | Cadence Design Systems (CDNS) | “It is possible that the integration process could result in the loss of key employees, the disruption of each company's ongoing businesses or inconsistencies in standards, controls, procedures, and policies that adversely affect the companies' ability to maintain relationships with clients, customers, depositors, and colleagues or to achieve the anticipated benefits and cost savings of the Cadence Merger.” |
| Partner | Veritex Holdings | “Our 2025 results reflect strong growth across loans, deposits, and value-added fee services, supported by the combination of existing and new businesses, and our partnership with Veritex.” |
Quoted from the company's 10-K filed Feb 13, 2026.
HBAN analyst estimates and revisions
| Period | EPS estimate | 90 days ago | Change | Revenue estimate | Analysts |
|---|---|---|---|---|---|
| Current quarter (ends Dec 2026) | $0.40 | $0.44 | -8.3% | $2.86B | 15 |
| Next quarter (ends Mar 2027) | $0.40 | $0.44 | -8.2% | $2.86B | 12 |
| Current fiscal year (ends Dec 2026) | $1.55 | $1.60 | -3.2% | $11.12B | 17 |
| Next fiscal year (ends Dec 2027) | $1.75 | $1.89 | -7.3% | $11.89B | 15 |
HBAN options: expected move
| Expiration | Days | ATM implied volatility | Expected move |
|---|---|---|---|
| Nov 20, 2026 | 28 | 24.2% | ±5.7% |
| Dec 18, 2026 | 56 | 23.8% | ±8.1% |
| Jan 15, 2027 | 84 | 27.8% | ±10.9% |
| Feb 19, 2027 | 119 | 26.1% | ±12.0% |
| Mar 19, 2027 | 147 | 28.8% | ±14.9% |
| Apr 16, 2027 | 175 | 25.0% | ±13.9% |
| May 21, 2027 | 210 | 24.3% | ±14.7% |
| Aug 20, 2027 | 301 | 29.8% | ±20.7% |
30-day implied volatility 24.3% vs 24.1% realized over the last 30 trading days. Put/call ratio (volume) 0.6. Cboe delayed quotes (15 min). Expected move = at-the-money straddle.
Key Statistics (as of October 23, 2026 at 08:35 UTC)
| Price | USD 15.66 |
|---|---|
| Change | ▼ 0.38% (down) |
| Previous Close | USD 15.72 |
| Open | USD 15.53 |
| Day Range | USD 15.47 – 15.89 |
| 52-Week Range | USD 14.82 – 19.46 |
| Volume | 33,632,816 shares |
| Market Cap | $31.64B |
| Exchange | NMS |
Technical Analysis (HBAN)
Nexqual's technical model rates HBAN "NEUTRAL" based on 2 bullish and 3 bearish signals across 127 daily candles, as of October 23, 2026 at 08:35 UTC.
| Overall Signal | NEUTRAL |
|---|---|
| RSI (14) | 47.63 (neutral) |
| vs SMA50 | Below (USD 16.18) |
| MACD | -0.16 (negative) |
Analyst Ratings (HBAN)
Wall Street analysts rate HBAN "Buy" based on 21 analysts, with a mean price target of USD 19.07 (range USD 17–22.5), per Nexqual as of October 23, 2026 at 08:35 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 21 |
| Mean Target | USD 19.07 |
| High Target | USD 22.5 |
| Low Target | USD 17 |
| Buy / Hold / Sell | 15 / 6 / 0 |
Earnings (HBAN)
| Next Earnings Date | 2026-10-22 |
|---|---|
| EPS Estimate | USD 0.4 |
| Revenue Estimate | $2.86B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-09-30 | USD 0.38 vs est 0.38 ▼ miss |
| 2026-06-30 | USD 0.39 vs est 0.39 ▲ beat |
| 2026-03-31 | USD 0.37 vs est 0.35 ▲ beat |
| 2025-12-31 | USD 0.37 vs est 0.38 ▼ miss |
Source: Nexqual, October 23, 2026 at 08:35 UTC.
Financials & Fundamentals (HBAN)
| Total Revenue | $9.18B |
|---|---|
| Revenue Growth (latest quarter, YoY) | +47.60% |
| Gross Margin | +0.00% |
| Operating Margin | +41.93% |
| Profit Margin | +26.13% |
| ROE | +9.00% |
| Total Cash | $16.61B |
| Total Debt | $22.61B |
Source: Nexqual, October 23, 2026 at 08:35 UTC.
Financial Health Score (HBAN)
Nexqual rates Huntington Bancshares Incorporated's overall financial health "Mixed" across five dimensions, as of October 23, 2026 at 08:35 UTC.
| Growth | Solid — Revenue +11% YoY (annual) |
|---|---|
| Profitability | Strong — Net margin 25% (last 12 months); banks have no gross margin |
| Balance Sheet | N/A — Not comparable for banks: deposits and customer funds sit on the balance sheet, so cash vs debt does not measure safety (SEC industry: National Commercial Banks) |
| Cash Flow | N/A — Not meaningful for banks and lenders: lending and trading move operating cash flow by billions each year (SEC industry: National Commercial Banks) |
| Efficiency | Mixed — ROE 9%, ROA 1.0% |
Ownership (HBAN)
| Insider Ownership | +0.80% |
|---|---|
| Institutional Ownership | +90.23% |
| Shares Outstanding | 2.02B |
| Float | 2.01B |
| Short % of Float | +2.73% |
Source: Nexqual, October 23, 2026 at 08:35 UTC.
Leadership (HBAN)
Huntington Bancshares Incorporated is led by Stephen D. Steinour, Chairman & CEO, per Nexqual as of October 23, 2026 at 08:35 UTC.
| Chairman & CEO | Stephen D. Steinour |
|---|---|
| President | Brantley J. Standridge |
| CFO & Senior EVP | Zachary J. Wasserman |
| Senior Executive Vice President | Helga S. Houston |
| Senior Executive VP & President of Commercial Banking | Scott D. Kleinman |
Major Backers & Investors (HBAN)
Notable institutional backers of Huntington Bancshares Incorporated include Wellington Management, Price (T.Rowe) Associates Inc, Invesco, according to Nexqual as of October 23, 2026 at 08:35 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Wellington Management | 6.05% |
| Price (T.Rowe) Associates Inc | 3.57% |
| Invesco | 3.53% |
| Boston Partners | 2.62% |
| FMR, LLC | 2.51% |
| Fidelity | 1.3% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 11.22% |
| BlackRock | 8.75% |
| State Street | 4.8% |
| Geode Capital | 2.89% |
Source: Nexqual, October 23, 2026 at 08:35 UTC.
From Huntington Bancshares Incorporated's Latest SEC 10-K Filing (filed 2026-02-13)
Key Strengths & Strategy (as disclosed to the SEC)
- We have a robust risk assessment process which includes qualitative and quantitative components that assess our inherent risk, control environment, and residual risk, and enables us to report to the Board if we are operating within the risk appetite.
- Our Chief Auditor reports directly to the Audit Committee. •Our Technology Committee oversees technology and cybersecurity strategies and plans and is charged with evaluating the Company's ability to properly perform all technology functions necessary for its business plan, including projected growth, technology capacity, planning, operational execution, product development, and management capacity.
- As we have expanded our C&I portfolio, we have developed a series of "vertical specialties" to ensure that new products or lending types are embedded within a structured, centralized Commercial Lending area with designated, experienced credit officers.
- Our portfolio management strategies associated with our Home Savers group allow us to focus on effectively helping our customers with appropriate solutions for their specific circumstances.
Partnerships
- Our 2025 results reflect strong growth across loans, deposits, and value-added fee services, supported by the combination of existing and new businesses, and our partnership with Veritex.
- Generally, these loans are for construction projects that have been pre-sold or pre-leased, or have secured permanent financing, as well as loans to real estate companies with significant equity invested in each project.
Legal & Regulatory Risks (Item 1A, quoted)
- We operate in a highly regulated industry, and the laws and regulations that govern our operations, corporate governance, executive compensation and financial accounting, or reporting, including changes in them, or our failure to comply with them, may adversely affect us and our business model.
- The resolution of significant pending litigation, if unfavorable, could have an adverse effect on our results of operations for a particular period.
- We depend on our executive officers and key personnel to continue the implementation of our long-term business strategy and could be harmed by the loss of their services.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BBD | Banco Bradesco Sa | USD 3.95 | ▼ 2.47% |
| FITB | Fifth Third Bancorp | USD 53.23 | ▲ 0.8% |
| DB | Deutsche Bank AG | USD 31.48 | ▼ 2.39% |
| TFC | Truist Financial Corporation | USD 48.42 | ▲ 1.45% |
| NWG | NatWest Group plc | USD 16.99 | ▼ 2.3% |
| NU | Nu Holdings Ltd. | USD 14.73 | ▼ 2.13% |
Data source: Nexqual — market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: October 23, 2026 at 08:35 UTC. This page is informational and not investment advice.
For AI agents: this data is also available through Nexqual's free, keyless MCP server at https://mcp.nexqual.com/mcp; every result includes source_url, as_of and cite_as. More: nexqual.com/agents · llms.txt